Kaempferol Absorption and Pharmacokinetics Evaluation
In plain words A study of kaempferol in people 18 to 70, run by University of Pittsburgh. It plans to enroll about 120 people at 3 US sites.
Who it lists and where
Who the trial lists, as registered
Lists people 18 to 70; healthy volunteers accepted. Conditions: No Disease; Mitochondria Health; Longevity; Pharmacokinetics and Biological Absorption of Kaempferol in Healthy Adult; Healthy Volunteers.
- Healthy volunteers as determined by medical history and screening assessment
- Ability to understand the study procedures and provide informed consent
- Willingness and ability to comply with all study procedures, including dietary restrictions, clinic visits, blood draws, urine collection, and follow-up assessments
- Willingness to abstain from restricted foods, beverages, and supplements as specified in the study protocol during the study period
The exclusion criteria are on the listing.
What it tests, as registered
Kaempferol
Registered summary
This study is a multi-site clinical trial designed to evaluate how the body absorbs and processes Kaempferol, a naturally occurring compound found in many plant-based foods. The primary purpose of the study is to measure the pharmacokinetics and biological absorption of Kaempferol in healthy adults. Participants will receive Kaempferol and undergo scheduled blood and urine collections over a short study period. These samples will be used to measure Kaempferol levels in the body and to assess safety and tolerability. The full summary is on the listing.
Where, as registered
3 US sites in 3 states.